Drugs that contain Fentanyl Citrate

1. Drug name - FENTORA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8119158 CEPHALON Effervescent oral fentanyl dosage form and methods of administering fentanyl Dec, 2024

(2 years from now)

US8092832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering Dec, 2024

(2 years from now)

US7862833 CEPHALON Effervescent oral opiate dosage forms and methods of administering opiates Jun, 2028

(5 years from now)

US7862832 CEPHALON Generally linear effervescent oral fentanyl dosage form and methods of administering Jun, 2028

(5 years from now)

Treatment: NA

Dosage: TABLET;BUCCAL, SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
EQ 0.1MG BASE TABLET;BUCCAL, SUBLINGUAL Prescription
EQ 0.2MG BASE TABLET;BUCCAL, SUBLINGUAL Prescription
EQ 0.3MG BASE TABLET;BUCCAL, SUBLINGUAL Discontinued
EQ 0.4MG BASE TABLET;BUCCAL, SUBLINGUAL Prescription
EQ 0.6MG BASE TABLET;BUCCAL, SUBLINGUAL Prescription
EQ 0.8MG BASE TABLET;BUCCAL, SUBLINGUAL Prescription

2. Drug name - LAZANDA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US8889176 BTCP PHARMA Method of managing or treating pain Jan, 2024

(1 year, 3 months from now)

US8216604 BTCP PHARMA Method of managing or treating pain Oct, 2024

(2 years from now)

US9731869 BTCP PHARMA Container Jan, 2032

(9 years from now)

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
EQ 0.1MG BASE SPRAY, METERED;NASAL Prescription
EQ 0.3MG BASE SPRAY, METERED;NASAL Discontinued
EQ 0.4MG BASE SPRAY, METERED;NASAL Prescription

3. Drug name - ONSOLIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9597288 BDSI Transmucosal delivery devices with enhanced uptake Jul, 2027

(4 years from now)

Treatment: Management of breakthrough pain in patients with cancer

Dosage: FILM;BUCCAL

More Information on Dosage
Strength Dosage Availability
EQ 0.2MG BASE FILM;BUCCAL Discontinued
EQ 0.4MG BASE FILM;BUCCAL Discontinued
EQ 0.6MG BASE FILM;BUCCAL Discontinued
EQ 0.8MG BASE FILM;BUCCAL Discontinued
EQ 1.2MG BASE FILM;BUCCAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.